APA (7th ed.) Citation

QH, L., YZ, W., J, T., CW, L., YJ, Y., R, L., . . . JN, Y. (2020). Anti-EGFR therapy in metastatic colorectal cancer: Mechanisms and potential regimens of drug resistance. Gastroenterology report, 8(3), 179. https://doi.org/10.1093/gastro/goaa026

Chicago Style (17th ed.) Citation

QH, Li, et al. "Anti-EGFR Therapy in Metastatic Colorectal Cancer: Mechanisms and Potential Regimens of Drug Resistance." Gastroenterology Report 8, no. 3 (2020): 179. https://doi.org/10.1093/gastro/goaa026.

MLA (9th ed.) Citation

QH, Li, et al. "Anti-EGFR Therapy in Metastatic Colorectal Cancer: Mechanisms and Potential Regimens of Drug Resistance." Gastroenterology Report, vol. 8, no. 3, 2020, p. 179, https://doi.org/10.1093/gastro/goaa026.